Cited by 438Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation

Open access

Zhang, Xian, Zhou, Kun, Wang, Ruishan, Cui, Jiankun, Lipton, Stuart A., Liao, Francesca-Fang, Xu, Huaxi, Zhang, Yun-wu·2007·Journal of Biological Chemistry

DOI 10.1074/jbc.m608856200

Open this paper in CoChat — free account

Abstract

The incidence of Alzheimer disease (AD) and vascular dementia is greatly increased following cerebral ischemia and stroke in which hypoxic conditions occur in affected brain areas. beta-Amyloid peptide (Abeta), which is derived from the beta-amyloid precursor protein (APP) by sequential proteolytic cleavages from beta-secretase (BACE1) and presenilin-1 (PS1)/gamma-secretase, is widely believed to trigger a cascade of pathological events culminating in AD and vascular dementia. However, a direct molecular link between hypoxic insults and APP processing has yet to be established. Here, we demonstrate that acute hypoxia increases the expression and the enzymatic activity of BACE1 by up-regulating the level of BACE1 mRNA, resulting in increases in the APP C-terminal fragment-beta (betaCTF) and Abeta. Hypoxia has no effect on the level of PS1, APP, and tumor necrosis factor-alpha-converting enzyme (TACE, an enzyme known to cleave APP at the alpha-secretase cleavage site). Sequence analysis, mutagenesis, and gel shift studies revealed binding of HIF-1 to the BACE1 promoter. Overexpression of HIF-1alpha increases BACE1 mRNA and protein level, whereas down-regulation of HIF-1alpha reduced the level of BACE1. Hypoxic treatment fails to further potentiate the stimulatory effect of HIF-1alpha overexpression on BACE1 expression, suggesting that hypoxic induction of BACE1 expression is primarily mediated by HIF-1alpha. Finally, we observed significant reduction in BACE1 protein levels in the hippocampus and the cortex of HIF-1alpha conditional knock-out mice. Our results demonstrate an important role for hypoxia/HIF-1alpha in modulating the amyloidogenic processing of APP and provide a molecular mechanism for increased incidence of AD following cerebral ischemic and stroke injuries.

Integrity signals

Registry

Crossref · 10.1074/jbc.m608856200

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
Cai, H., Wang, Y., McCarthy, D. B., Wen, H., Borchelt, D., Price, D. L., & Wong, P. C. (2001) · Nature Neuroscience · doi:10.1038/85064 · Cited by 1,087
Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase
Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0811 · Cited by 1,080
Constitutive and regulated α-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease
Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., & Fahrenholz, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3922 · Cited by 975
Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor
Buxbaum, J. D., Liu, K.-N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., & Black, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27765 · Cited by 952
Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729

Flagged first, then by citations

Show all 48 references

1 of the 48 references couldn’t be matched to a known paper.

Sorted by citations

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
Sleep, Cognitive impairment, and Alzheimer's disease: a systematic review and meta-analysis
Bubu, O. M., Brannick, M., Mortimer, J., Umasabor-Bubu, O., Sebastião, Y. V., Wen, Y., Schwartz, S., Borenstein, A. R., Wu, Y., Morgan, D., et al. (2017) · Sleep · doi:10.1093/sleep/zsw032 · Cited by 673
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., Kyrargyri, V., Pfeiffer, T., Khennouf, L., Madry, C., et al. (2019) · Science · doi:10.1126/science.aav9518 · Cited by 682
A review of the molecular aspects of melatonin’s anti‐inflammatory actions: recent insights and new perspectives
Mauriz, J. L., Collado, P. S., Veneroso, C. E., Reiter, R. J., & González‐Gallego, J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01014.x · Cited by 633
The Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential
Vassar, R., Kovacs, D. M., Yan, R., & Wong, P. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3657-09.2009 · Cited by 577
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
Molecular Pathogenesis of Alzheimer's Disease: An Update
Sanabria‐Castro, A., Echeverría, I. A., & Bonilla, C. M. (2017) · Annals of Neurosciences · doi:10.1159/000464422 · Cited by 427
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
Vassar, R. J. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0089-7 · Cited by 421
Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research
Bubu, O. M., Andrade, A. G., Umasabor-Bubu, O. Q., Hogan, M. M., Turner, A. D., de Leon, M. J., Ogedegbe, G., Ayappa, I., Jean-Louis G, G., Jackson, M. L., et al. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.101250 · Cited by 389
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor
Lonati, E., Brambilla, A., Milani, C., Masserini, M., Palestini, P., & Bulbarelli, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00001 · Cited by 348
Cerebrovascular disease in ageing and Alzheimer’s disease
Love, S., & Miners, J. S. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1522-0 · Cited by 299
Impact of sleep on the risk of cognitive decline and dementia
Spira, A. P., Chen-Edinboro, L. P., Wu, M. N., & Yaffe, K. S. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000106 · Cited by 331
Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease
Sadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1558-9 · Cited by 294
Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
Rosales‐Corral, S., Acuña-Castroviejo, D., Coto‐Montes, A. M., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 299
Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls
Ebrahimi, A., & Schluesener, H. J. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.01.006 · Cited by 279
Traumatic brain injury: A risk factor for Alzheimer's disease
Sivanandam, T. M., & Thakur, M. K. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.013 · Cited by 326
Vascular dysfunction in the pathogenesis of Alzheimer's disease — A review of endothelium-mediated mechanisms and ensuing vicious circles
Marco, L. Y. D., Venneri, A., Farkas, E., Evans, P. C., Marzo, A., & Frangi, A. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.014 · Cited by 260
Neurovascular Unit Dysfunction and Neurodegenerative Disorders
Yu, X., Ji, C., & Shao, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00334 · Cited by 244
The up‐regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α
Guglielmotto, M., Aragno, M., Autelli, R., Giliberto, L., Novo, E., Colombatto, S., Danni, O., Parola, M., Smith, M. A., Perry, G. L., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05858.x · Cited by 245
Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms
Rouch, L., Cestac, P., Hanon, O., Cool, C., Helmer, C., Bouhanick, B., Chamontin, B., Dartigues, J.-F., Vellas, B. J., & Andrieu, S. (2015) · CNS Drugs · doi:10.1007/s40263-015-0230-6 · Cited by 244
AMP‐activated protein kinase: a potential player in Alzheimer’s disease
Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H. S., & Hiltunen, M. O. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07331.x · Cited by 224
Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP
Li, L., Zhang, X., Yang, D., Luo, G., Chen, S., & Le, W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.011 · Cited by 220
Self-citation
Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly
Daulatzai, M. A. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23634 · Cited by 222
Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13932 · Cited by 206
Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer’s disease and vascular dementia
Thomas, T. L., Miners, J. S., & Love, S. (2015) · Brain · doi:10.1093/brain/awv025 · Cited by 194
Pathological role of hypoxia in Alzheimer's disease
Zhang, X., & Le, W. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.033 · Cited by 190
Self-citation
Cerebral Microvascular Injury: A Potentially Treatable Endophenotype of Traumatic Brain Injury-Induced Neurodegeneration
Sandsmark, D. K., Bashir, A., Wellington, C. L., & Diaz-Arrastia, R. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.002 · Cited by 180
From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration
Zhao, Y., & Gong, C.-X. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0127-9 · Cited by 180
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Bjerke, M., Zetterberg, H., Edman, Å., Blennow, K., Wallin, A., & Andreasson, U. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110566 · Cited by 180
Blood pressure and the risk for dementia—A double edged sword
Kennelly, S. P., Lawlor, B. A., & Kenny, R. A. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.11.001 · Cited by 173
Mitochondria-targeted catalase reduces abnormal APP processing, amyloid production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension
Mao, P., Mańczak, M., Calkins, M. J., Truong, Q., Reddy, T. P., Reddy, A. P., Shirendeb, U. P., Lo, H., Rabinovitch, P. S., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds128 · Cited by 176
Interactions between APP secretases and inflammatory mediators
Sastre, M., Walter, J., & Gentleman, S. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-25 · Cited by 178
Cell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia
Engelhardt, S., Patkar, S., & Ogunshola, O. O. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12489 · Cited by 168
BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease
Chami, L., & Checler, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-52 · Cited by 168
Obstructive Sleep Apnea and Longitudinal Alzheimer's Disease Biomarker Changes
Bubu, O. M., Pirraglia, E., Andrade, A. G., Sharma, R. A., Giménez, S., Umasabor‐Bubu, O. Q., Hogan, M. M., Shim, A., Mukhtar, F., Sharma, N. K., et al. (2018) · SLEEP · doi:10.1093/sleep/zsz048 · Cited by 176
Review: Blood pressure and dementia — a comprehensive review
Kennelly, S., LAWLOR, B. A., & Kenny, R. A. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609103483 · Cited by 168
Chronic Intermittent Hypoxia/Reoxygenation Facilitate Amyloid-β Generation in Mice
Shiota, S., Takekawa, H., Matsumoto, S., Takeda, K., Nurwidya, F., Yoshioka, Y., Takahashi, F., Hattori, N., Tabira, T., Mochizuki, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130419 · Cited by 155
Obstructive sleep apnea decreases central nervous system–derived proteins in the cerebrospinal fluid
Ju, Y. S., Finn, M. B., Sutphen, C. L., Herries, E. M., Jerome, G. M., Ladenson, J. H., Crimmins, D. L., Fagan, A. M., & Holtzman, D. M. (2016) · Annals of Neurology · doi:10.1002/ana.24672 · Cited by 168
Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer’s disease
Gupta, A. K., & Iadecola, C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00115 · Cited by 163
Oxidative Stress and Transcriptional Regulation in Alzheimer Disease
Shi, Q., & Gibson, G. E. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815721c3 · Cited by 158
From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s Disease
Leuner, K., Müller, W. E., & Reichert, A. S. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8307-4 · Cited by 160
Hypoxia‐inducible factors as neuroprotective agent in Alzheimer's disease
Ashok, B. S., Ajith, T. A., & Sivanesan, S. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12717 · Cited by 150
Insulin-Degrading Enzyme Sorting in Exosomes: A Secretory Pathway for a Key Brain Amyloid-β Degrading Protease
Bulloj, A., Leal, M. C., Xu, H., Castaño, E. M., & Morelli, L. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1206 · Cited by 149
Self-citation
The Vascular Hypothesis of Alzheimer’s Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging
de la Torre, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180004 · Cited by 161
Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus
Ali, T., Yoon, G. H., Shah, S. A., Lee, H. Y., & Kim, M. O. (2015) · Scientific Reports · doi:10.1038/srep11708 · Cited by 146
The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin
Peters, D. G., Connor, J. R., & Meadowcroft, M. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.007 · Cited by 146
Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia
Roher, A. E., Tyas, S. L., Maarouf, C. L., Daugs, I. D., Kokjohn, T. A., Emmerling, M. R., Garami, Z. F., Bëlohlávek, M., Sabbagh, M. N., Sue, L. I., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.08.228 · Cited by 144
Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer's disease
Troussière, A., Charley, C. M., Salleron, J., Richard, F., Delbeuck, X., Derambure, P., Pasquier, F., & Bombois, S. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307544 · Cited by 143
Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease
Roher, A. E., Garami, Z. F., Tyas, S. L., Maarouf, C. L., Kokjohn, T. A., Bëlohlávek, M., Vedders, L. J., Connor, D. J., Sabbagh, M. N., Beach, T. G., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.09.002 · Cited by 138
Oligemic Hypoperfusion Differentially Affects Tau and Amyloid-β
Koike, M. A., Green, K. N., Blurton-Jones, M., & LaFerla, F. M. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090750 · Cited by 130
Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors
Guglielmotto, M. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.003.2010 · Cited by 135
Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease
Yezhuvath, U. S., Uh, J., Cheng, Y., Martin‐Cook, K., Weiner, M., Diaz-Arrastia, R. R., van Osch, M. J. P., & Lu, H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.005 · Cited by 131
Alzheimer's β-Secretase (BACE1) Regulates the cAMP/PKA/CREB Pathway Independently of β-Amyloid
Chen, Y., Huang, X., Zhang, Y.-W., Rockenstein, E., Bu, G., Golde, T. E., Masliah, E., & Xu, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0757-12.2012 · Cited by 117
Self-citation
Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives
Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 133
Cardiovascular risk factors, cortisol, and amyloid‐β deposition in Alzheimer's Disease Neuroimaging Initiative
Toledo, J. B., Toledo, E., Weiner, M. W., Jack, C. R., Jagust, W., Lee, V. M. ‐., Shaw, L. M. J., & Trojanowski, J. Q. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.08.008 · Cited by 130
Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease
Mitroshina, Е. V., Saviuk, M. O., Ponimaskin, E. G., & Vedunova, M. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703084 · Cited by 136
Vascular risk factors and Alzheimer’s disease
Cechetto, D. F., Hachinski, V., & Whitehead, S. N. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.743 · Cited by 133
Contribution of hypoxia to Alzheimer’s disease: is HIF-1α a mediator of neurodegeneration?
Ogunshola, O. O., & Antoniou, X. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0141-0 · Cited by 128
Cerebrovascular disease, beta-amyloid, and cognition in aging
Marchant, N. L., Reed, B. R., DeCarli, C. S., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.001 · Cited by 127
Central artery stiffness, neuropsychological function, and cerebral perfusion in sedentary and endurance-trained middle-aged adults
Tarumi, T., Gonzales, M. M., Fallow, B. A., Nualnim, N., Pyron, M. I., Tanaka, H., & Haley, A. P. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328364decc · Cited by 134
High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner
Gannon, O. J., Robison, L. S., Salinero, A. E., Abi-Ghanem, C., Mansour, F. M., Kelly, R. D., Tyagi, A., Brawley, R. R., Ogg, J. D., & Zuloaga, K. L. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02466-2 · Cited by 127
Causes and consequences of baseline cerebral blood flow reductions in Alzheimer’s disease
Bracko, O., Hernández, J. C. C., Park, L., Nishimura, N., & Schaffer, C. B. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20982383 · Cited by 127
BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
Koelsch, G. (2017) · Molecules · doi:10.3390/molecules22101723 · Cited by 128
Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges
Lee, S., Mankhong, S., & Kang, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071728 · Cited by 129
The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction
Marchant, N. L., Reed, B. R., Sanossian, N., Madison, C. M., Kriger, S., Dhada, R., Mack, W. J., DeCarli, C., Weiner, M. W., Mungas, D. M., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.405 · Cited by 106
Amyloid Beta Resistance in Nerve Cell Lines Is Mediated by the Warburg Effect
Newington, J. T., Pitts, A., Chien, A., Arseneault, R., Schubert, D. A., & Cumming, R. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019191 · Cited by 121
Hypoxia-Induced Down-Regulation of Neprilysin by Histone Modification in Mouse Primary Cortical and Hippocampal Neurons
Wang, Z., Yang, D., Zhang, X., Li, T., Li, J., Tang, Y., & Le, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019229 · Cited by 125
Self-citation
γ-Secretase Substrate Concentration Modulates the Aβ42/Aβ40 Ratio
Yin, Y. I., Bassit, B., Zhu, L., Yang, X., Wang, C., & Li, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704601200 · Cited by 115
Brain Ischemia Activates β- and γ-Secretase Cleavage of Amyloid Precursor Protein: Significance in Sporadic Alzheimer’s Disease
Pluta, R. M., Furmaga-Jabłońska, W., Maciejewski, R., Ułamek-Kozioł, M., & Jabłoński, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8360-z · Cited by 116
Amyloid-β Production: Major Link Between Oxidative Stress and BACE1
Tamagno, E., Guglielmotto, M., Monteleone, D., & Tabaton, M. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9283-6 · Cited by 117
Involvement of calpain in the neuropathogenesis of Alzheimer’s disease
Mahaman, Y. A. R., Huang, F., Afewerky, H. K., Salissou, M. T. M., Bishwajit, G., & Wang, X. (2018) · Medicinal Research Reviews · doi:10.1002/med.21534 · Cited by 110
Death by a Thousand Cuts in Alzheimer’s Disease: Hypoxia—The Prodrome
Daulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9379-2 · Cited by 114
The magic of the hypoxia-signaling cascade
Benizri, E. I., Ginouvès, A., & Berra, E. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7472-0 · Cited by 112
Endothelin-1 is Elevated in Alzheimer's Disease and Upregulated by Amyloid-β
Palmer, J. C., Barker, R., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111760 · Cited by 110
Calpain Activation Promotes BACE1 Expression, Amyloid Precursor Protein Processing, and Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease
Liang, B., Duan, B.-Y., Zhou, X., Gong, J., & Luo, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117960 · Cited by 109
Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Parodi‐Rullán, R. M., Sone, J. Y., & Fossati, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190357 · Cited by 110
Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice
Kitaguchi, H., Tomimoto, H., Ihara, M., Shibata, M., Uemura, K., Kalaria, R. N., Kihara, T., Asada-Utsugi, M., Kinoshita, A., & Takahashi, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.078 · Cited by 108
Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities
Merelli, A., Rodríguez, J., Folch, J., Regueiro, M. R., Camins, A., & Lazarowski, A. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180110130253 · Cited by 106
BACE1: More than just a β‐secretase
Taylor, H. A., Przemylska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 107
Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome
Bu, X.-L., Liu, Y.-H., Wang, Q.-H., Jiao, S.-S., Zeng, F., Yao, X., Gao, D., Chen, J.-C., & Wang, Y.-J. (2015) · Scientific Reports · doi:10.1038/srep13917 · Cited by 98
The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: Characterizing a new regulatory motif
Maloney, B., & Lahiri, D. K. (2011) · Gene · doi:10.1016/j.gene.2011.06.004 · Cited by 112
Cerebral Small Vessel Disease and Alzheimer's Disease: A Review
Kim, H. W., Hong, J., & Jeon, J. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00927 · Cited by 111
Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape
Salminen, A., Haapasalo, A., Kauppinen, A., Kaarniranta, K., Soininen, H. S., & Hiltunen, M. O. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.001 · Cited by 107
Differential regulation of BACE1 expression by oxidative and nitrosative signals
Kwak, Y.-D., Wang, R., Li, J. J., Zhang, Y., Xu, H., & Liao, F. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-17 · Cited by 105
Self-citation
Cerebral small vessel disease and the risk of Alzheimer’s disease: A systematic review
Liu, Y., Braidy, N., Poljak, A., Chan, D. K. Y., & Sachdev, P. S. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.06.002 · Cited by 107
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimers Disease
Vassar, R. J., & Cole, S. (2007) · Current Genomics · doi:10.2174/138920207783769512 · Cited by 108
Kinetics and molecular docking studies of fucosterol and fucoxanthin, BACE1 inhibitors from brown algae Undaria pinnatifida and Ecklonia stolonifera
Jung, H. A., Ali, M. Y., Choi, R. J., Jeong, H. O., Chung, H. Y., & Choi, J. S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.01.014 · Cited by 99
BACE1 Structure and Function in Health and Alzheimers Disease
Cole, S., & Vassar, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954758 · Cited by 98
Regulation of β‐site APP‐cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease
Sun, X., Bromley‐Brits, K., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07515.x · Cited by 97
The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond
Dislich, B., & Lichtenthaler, S. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00008 · Cited by 102
Correlating Cognitive Decline with White Matter Lesion and BrainAtrophy Magnetic Resonance Imaging Measurements in Alzheimer’s Disease
Bilello, M., Doshi, J. J., Nabavizadeh, S. A., Toledo, J. B., Erus, G., Xie, S. X., Trojanowski, J. Q., Han, X., & Davatzikos, C. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150400 · Cited by 93
Can sleep apnea cause Alzheimer's disease?
Pan, W., & Kastin, A. J. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.019 · Cited by 91
Matrix Metalloproteinase (MMP)-9 Induced by Wnt Signaling Increases the Proliferation and Migration of Embryonic Neural Stem Cells at Low O2 Levels
Ingraham, C. A., Park, G. C., Makarenkova, H. P., & Crossin, K. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229427 · Cited by 88
Synaptic protein levels altered in vascular dementia
Sinclair, L. I., Tayler, H. M., & Love, S. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12215 · Cited by 86
The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 87
IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function
Montemurro, C., Nomoto, H., Pei, L., Parekh, V. S., Vongbunyong, K. E., Vadrevu, S., Gurlo, T., Butler, A. E., Subramaniam, R., Ritou, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10444-1 · Cited by 86
Function, regulation and therapeutic properties of β-secretase (BACE1)
Willem, M., Lammich, S., & Haass, C. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.003 · Cited by 87

Authors: Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W.
Affiliations: Sanford Burnham Prebys Medical Discovery Institute (US)
Shanghai Jiao Tong University (CN)
Corresponding author: Xu, Huaxi
ORCID: Zhang, Xian
Zhou, Kun
Wang, Ruishan
Cui, Jiankun
Lipton, Stuart A.
Liao, Francesca-Fang
Xu, Huaxi
Zhang, Yun-wu
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2007-04
Volume: 282
Issue: 15
Pages: 10873-10880
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m608856200
OpenAlex: W2030333049
Semantic Scholar: eb4c044d3442f536df662e6d66780f400d3ccdf9
Cited by: 436
References: 48
Citations by year: 2026: 22 · 2025: 27 · 2024: 26 · 2023: 18 · 2022: 23 · 2021: 23 · 2020: 13 · 2019: 16 · 2018: 24 · 2017: 15 · 2016: 20 · 2015: 28 · 2014: 34 · 2013: 22 · 2012: 29
FWCI: 14.34
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 4922 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: National Institute on Aging (R01AG030197, R01 AG021173)
National Institute of Neurological Disorders and Stroke (R01NS046673, R01NS054880)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: hypoxia, HIF-1α, BACE1, amyloid-beta, Alzheimer's disease, vascular dementia, APP processing, beta-secretase, cerebral ischemia, stroke, hippocampus, cerebral cortex
MeSH terms: Animals, Base Sequence, Binding Sites, Brain, Cell Line, Humans, Molecular Sequence Data, Promoter Regions, Genetic, Time Factors, Transcription, Genetic, Cell Hypoxia, Up-Regulation, Gene Expression Regulation, Enzymologic, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Mice, Knockout, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks